A. Gonzalez Martin - 1Medical Oncology Department, Clinica Universidad de Navarra

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 51 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

LBA29 Final Overall Survival (OS) in Patients (pts) with Newly Diagnosed Advanced Ovarian Cancer (aoc) Treated with Niraparib (nir) First-Line (1L) Maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012

A. González-Martín, B. Pothuri,M.P. Barretina Ginesta, W.S. Graybill,I.B. Vergote, C. McCormick, M.R. Mirza, R.G. Moore, D. Lorusso,R.E. O'Cearbhaill, G. Freyer, D.M. O'Malley, F. Heitz, M.S. Shahin, I. Bruchim, W.H. Bradley, N. Compton, I. Malinowska, A. Redondo, B.J. Monk

Annals of Oncology (2024)

Cited0Views0Bibtex

748P Phase II Dose Optimization with EZH2/EZH1 Inhibitor Tulmimetostat in Patients with ARID1A-mutated Ovarian Clear Cell Carcinoma

A. Oaknin,C. Drescher, K. Banda,L. Duska, V. Ribrag, A. Tewari,N.J. Lakhani,L. Eberst, R.D. Harvey,L.M. Manso Sanchez, D. Lorusso, H. Kindler,H.S. Walter,D.G. Illescas,E. Pons-Tostivint, A.G. Thakur, L. Kann, A. Reddy, N. Faulhaber,A. González-Martín

Annals of Oncology (2024)

Cited0Views0Bibtex

232P Identification of ‘secondary’ Germline Cancer Predisposition Variants from Somatic Tumour Testing: Should We Evolve Towards Universal Screening

A. Gallego Martinez,T. Imizcoz, L. Sanchez-Lorenzo,M. Mora, D. Dominguez,A. Gurpide, J. Espinos Jimenez,J. M. Aramendia,A. Chopitea Ortega, M. Santisteban Eslava,M. Ponz-Sarvise, L. Gonzalez, A. Landa Magdalena,M. F. Sanmamed, G. Alkorta-Aranburu, Rodriguez, T. Herraiz Bayod,A. Gonzalez Martin,A. Patino-Garcia

Annals of oncology (2023): S274-S274

Cited0Views0Bibtex

795P Tolerability and Effectiveness of Niraparib in Long-Term Responders with Platinum-Sensitive Recurrent Ovarian Cancer (GEICO-88R Study)

J.F. Cueva Banuelos,C. Salvador Coloma,F. Galvez Montosa, J. Ferreiro Quintana,S. Cros Costa,S. González-Santiago, J.G. Cassinello,M. Romeo Marin, P. Reche,M.L. Soriano Tabares,M. Valero Arbizu,M.J. Rubio Perez, H.M. Oré Arce,L. Gaba Garcia, M.D.M. Gordon Santiago,C. Gomez Raposo,S. Hernando Polo,R. Marquez Vazquez,J. Fuentes Pradera,A. Gonzalez Martin

Annals of oncology (2023): S533-S533

Cited0Views0Bibtex

33O PRIMA/ENGOT-OV26/GOG-3012 Study: Long-term Conditional PFS

A.J. Gonzalez Martin,B. Pothuri,I.B. Vergote,W. Graybill,M.R. Mirza,C. McCormick,D. Lorusso,G. Freyer,F. Backes,F. Heitz,A. Redondo Sanchez, R. Moore,C. Vulsteke,R.E. O'Cearbhaill,I. Malinowska,L. Shtessel, W. York,B.J. Monk

ESMO open（2023）

Cited1Views0Bibtex

741MO Luveltamab Tazevibulin (STRO-002), an Anti-Folate Receptor Alpha (folrα) Antibody Drug Conjugate (ADC), Demonstrates Clinical Activity in Recurrent/progressive Epithelial Endometrial Cancer (EEC): STRO-002-GM1 Phase I Dose Expansion

B. Pothuri,R.W. Naumann,L.P. Martin,D. O'Malley,D. Uyar,J.W. Moroney,J. Diaz,J. Garcia-Donas,A. Redondo Sanchez,A. Gonzalez Martin,D.G. Illescas, L. Liu,C. Berman,A. Oaknin

Annals of oncology (2023): S508-S508

Cited0Views0Bibtex

REFRaME-O1/ENGOT-OV79/GOG-3086: A Phase II/III Open-Label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice of Chemotherapy in Women with Relapsed Platinum-Resistant Epithelial Ovarian Cancer Expressing Folate Receptor Alpha (Folr)

R. W. Naumann,A. Gonzalez Martin, T. J. Herzog, R. L. Coleman, I. L. Ray-Coquard, R. Miller, L. Lu, H. Dokainish, C. Berman, A. Oaknin

ANNALS OF ONCOLOGY (2023): S540-S541

Cited0Views0Bibtex

818Tip REFRaME-O1/ENGOT-OV79/GOG-3086: A Phase II/III Open-Label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator’s Choice of Chemotherapy in Women with Relapsed Platinum-Resistant Epithelial Ovarian Cancer Expressing Folate Receptor Alpha (Folrα)

R.W. Naumann,A. Gonzalez Martin,T.J. Herzog,R.L. Coleman,I.L. Ray-Coquard, R. Miller, L. Lu, H. Dokainish,C. Berman,A. Oaknin

Annals of Oncology (2023): S540-S541

Cited0Views0Bibtex

Atezolizumab Combined with Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer with a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial

A. Gonzalez Martin,M. J. Rubio Perez, F. Heitz,R. D. Christensen, N. Colombo,T. Van Gorp,A. Oaknin,A. Leary,L. Gaba Garcia,C. Lebreton,L. M. De Sande Gonzalez,M. Romeo Marin,A. Redondo,M. P. Barretina Ginesta,J. A. Perez Fidalgo,A. Santaballa Bertran, M. J. Bermejo-Perez, I. Bruchim, I. L. Ray-Coquard,F. Selle

ANNALS OF ONCOLOGY (2023): S1278-S1279

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn